Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01501539 · ClinicalTrials.gov registry record · NA

Prevention of Hypergranulation Tissue After Gastrostomy Tube Placement

A NA study of Soft Tissue Inflammation, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Completed
Registry status
NA
Development phase
171
Enrollment target
1
Study location

NCT01501539: Completed NA study of Soft Tissue Inflammation, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

NCT01501539 is a NA study of Soft Tissue Inflammation that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 171 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01501539, a NA study of Soft Tissue Inflammation, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

COMPLETED
Registry status
NA
Development phase
171 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to compare the incidence of postoperative hypergranulation tissue formation after gastrostomy tube placement among children randomized to one of three treatments, in addition to measuring tube dislodgements and rates of resource utilization for complications.

Conditions Studied

Interventions

  • PROCEDURE Standard Hydrocolloid Dressing
  • PROCEDURE Silver Hydrocolloid Dressing

Study Locations (1)

Illinois

  • Children's Memorial Hospital - Chicago

Trial Details

FieldValue
Enrollment Target 171 participants
Start Date 2010-12
Est. Completion 2017-06
Phase NA

What the finished NCT01501539 record still lists

NCT01501539 is an interventional study that assigns participants to a tested intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Soft Tissue Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Standard Hydrocolloid Dressing is the first listed.

NCT01501539 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01501539 about?

NCT01501539 is a clinical study titled "Prevention of Hypergranulation Tissue After Gastrostomy Tube Placement". The primary objective of this study is to compare the incidence of postoperative hypergranulation tissue formation after gastrostomy tube placement among children randomized to one of three treatments, in addition to measuring tube dislodgements and rates of resource utilization for complications.

What is the current status of trial NCT01501539?

This trial is currently completed. It is a NA study. The enrollment target is 171 participants. The study started on 2010-12. Estimated completion is 2017-06.

What conditions does trial NCT01501539 study?

This clinical trial studies the following conditions: Soft Tissue Inflammation.

What interventions are being tested in trial NCT01501539?

The interventions under investigation include: Standard Hydrocolloid Dressing (PROCEDURE), Silver Hydrocolloid Dressing (PROCEDURE).

Who is sponsoring clinical trial NCT01501539?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01501539 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT01501539's enrollment target sits among peer trials

171 612th of 2000 higher than 1,387 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02641145 · 171 participants · NA

    Molecular Imaging of Primary Amyloid Cardiomyopathy

  • NCT05541029 · 171 participants · NA

    Music Listening: A Mechanistic Trial

  • NCT05561127 · 171 participants · Phase 3

    Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

  • NCT05592938 · 171 participants · NA

    Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01501539, the US trial registry maintained by the National Library of Medicine. NCT01501539 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.